By SETH JOSEPH This is part 3 of Seth’s series about Epic that has generated much interest and a little controversy and we are happy to host it on THCB. Part 1 and Part 2 were published on Forbes earlier this year. According to people in the room, Judy Faulkner’s vision on stage at Epic’s…
Emory Healthcare in Atlanta announced a partnership with Guidehealth, value-based care enablement startup. The collaboration is designed to help primary care reach more than 350,000 patients across Georgia. The post How Emory’s New Partnership Seeks to Scale Value-Based Care Across Georgia appeared first on MedCity News.
Evvy has launched a new line of prescription products to relieve vaginal discomfort. The products are available on the company’s website, with prices ranging from $35 to $59. The post Evvy Introduces Treatments for Common Vaginal Symptoms appeared first on MedCity News.
That is the title of an ISPOR Europe panel I saw with Hugo Pedder, Jeroen Jansen, Dawn Lee and Mark Harries. The goal of sequential pathways model is to be able to answers questions like (i) how does a new treatment impact the cost and effectiveness for patients within a sequence of treatment, or (ii)…
BOISE, Idaho — Physicians are expected to take the stand in Idaho’s capital on Tuesday to argue that the state’s near-total prohibition of abortion care is jeopardizing women’s health, forcing them to carry fetuses with deadly anomalies, and preventing doctors from intervening in potentially fatal medical emergencies. Their testimony is scheduled to lead off the…
Approval of Syndax’s Revuforj for acute leukemia makes the twice-daily pill the first in a new class of drugs that block a cancer-driving protein called menin. Other companies developing menin inhibitors include Kura Oncology, Biomea Fusion, and Johnson & Johnson subsidiary Janssen. The post Syndax Pharmaceuticals Leukemia Drug Wins a First-in-Class FDA Approval appeared first…
This analysis examines the extent to which large private and non-federal public employers that offer retiree health benefits are turning to Medicare Advantage and why they are making this shift, using data from the 2024 Employer Health Benefits Survey. We find that slightly more than half (56%) of large employers offering retiree health benefits to…
Despite AI’s growing ability to simulate empathy and even outperform humans in some areas of emotional awareness, can it truly replace human therapists and take the burden off the mental health care system? The post Why AI Won’t Replace Human Psychotherapists appeared first on MedCity News.
Early diagnosis through blood tests buys invaluable time – for patients and their families to plan, seek support, make informed decisions about their difficult care journey and, perhaps most importantly, be together. The post Why We Urgently Need More Widely Available Tests for Alzheimer’s Disease appeared first on MedCity News.
This policy watch provides an update on the latest trends in children’s routine vaccination and exemption rates and discusses how these trends could be impacted by the administration change.